“Historic moment:” Today, the FDA gave Biogen’s investigational Alzheimer’s drug aducanumab its approval, with the requirement that they conduct a post-approval trial. UPDATE: 3…
Image: Phil Gutis receives an aducanumab infusion while carrying out his “silly shoe challenge.” Phil Gutis reflects on the significance of participating in the…
Biogen’s aducanumab — a human antibody-based drug that targets beta-amyloid plaques, which are found in the brains of people with Alzheimer’s — has gone…
“It’s Time for More Time” With the #MoreTime campaign, the Alzheimer’s Association has gone all in on aducanumab, the controversial new Alzheimer’s drug produced…
Biogen’s Alzheimer’s drug aducanumab encounters another bump in the road as the FDA delays its approval decision. The Federal Drug Administration has given itself…
Even though the Alzheimer’s drug aducanumab has faced many twists and turns along its path to FDA approval, experts say that approval of Biogen’s…
In a surprising turn of events, the Advisory Committee of experts on Biogen’s experimental Alzheimer’s drug aducanumab recommended against FDA approval of the drug…
UPDATE: 3 March 2024, 8:19 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Today, the public gets a preview of FDA staff recommendations and drugmaker presentations in advance of this Friday’s advisory committee meeting to discuss Biogen’s…
It would be a game changer. Not because Aducanumab is a cure – but it would be a start in disease modifying treatments for…
The side effect that has been feared is the risk of brain swelling. We call this aria, and there is also a side of…
That will probably be the next step. After phase 3 studies, once we are satisfied with the data set and we can prove that…
For people who were previously in the trial, they will be re-invited to join a two year study and re-grouped based on how their…
Aducanumab is an anti-body given to patients through an intravenous infusion. This antibody, in high dosages, goes into the brain and binds to a…